nbqx (Alomone Labs)


Structured Review

Nbqx, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbqx/product/Alomone Labs
Average 94 stars, based on 13 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection"
Article Title: NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection
Journal: Experimental neurology
doi: 10.1016/j.expneurol.2016.04.010

Figure Legend Snippet: Gliosis within the hippocampus and dentate gyrus of antagonist-treated mice. TMEV-infected C57BL/6J mice were treated with MK 801, GYKI-52466 and NBQX or with PBS as a control (treatment: day 2.5–10.5 post infection). Mice were sacrificed on day 21 post infection. Gliosis was scored as described in the Methods. The number of mice in each group is given as N above each column. Data is given as mean + SEM. †p
Techniques Used: Mouse Assay, Infection

Figure Legend Snippet: Weight change in antagonist-treated mice. TMEV-infected C57BL/6J mice were treated with MK 801, GYKI-52466 and NBQX or with PBS as a control (treatment: day 2.5–10.5 post infection). Mice were weighed daily through day 21 post infection. Data represents percent of daily weight in comparison to weight at day −1, given as mean ± standard error of the mean (SEM) for groups of 20 mice (MK 801, GYKI-52466), 19 mice (NBQX) and 60 mice (PBS). †p
Techniques Used: Mouse Assay, Infection

Figure Legend Snippet: Mortality in antagonist-treated mice. TMEV-infected C57BL/6J mice were treated with MK 801, GYKI-52466 and NBQX or with PBS as a control (treatment: day 2.5–10.5 post infection). Mice were monitored through day 21 post infection. Data represents percent daily survival in comparison to day 0. The numbers of mice per group at day 0 were 20 mice (MK 801, GYKI-52466), 19 mice (NBQX) and 60 mice (PBS). †p
Techniques Used: Mouse Assay, Infection

Figure Legend Snippet: Neuronal cell loss within the hippocampus of antagonist-treated mice. TMEV-infected C57BL/6J mice were treated with MK 801, GYKI-52466 and NBQX or with PBS as a control (treatment: day 2.5–10.5 post infection). Mice were sacrificed on day 21 post infection. A. Neuronal cell loss was scored as described in the Methods. The number of mice in each group is given as N above each column. Data is given as mean + SEM. †p
Techniques Used: Mouse Assay, Infection